TeraWulf
WULF
Bitdeer Technologies
BTDR
Riot Platforms
RIOT
Bitfarms
BITF
Strategy
MSTR
US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 6.330
- +0.130+2.10%
Close Feb 28 16:00 ET
- 6.330
- 0.0000.00%
Post 17:34 ET
562.08MMarket Cap-2.69P/E (TTM)
6.330High5.990Low1.63MVolume6.270Open6.200Pre Close10.14MTurnover2.51%Turnover RatioLossP/E (Static)88.80MShares16.50052wk High1.14P/B411.64MFloat Cap4.30552wk Low--Dividend TTM65.03MShs Float78.000Historical High--Div YieldTTM5.48%Amplitude4.305Historical Low6.222Avg Price1Lot Size
About Verve Therapeutics Company
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Company Profile
SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees274
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070
Websitehttp://www.vervetx.com
Company Executives
- Name
- Position
- Salary
- Dr. Sekar Kathiresan, M.D.
- Chief Executive Officer and Director
- 9.32M
- Frederick Fiedorek, M.D.
- Chief Medical Officer
- --
- Andrew D. Ashe, J.D.
- President and Chief Operating Officer
- --
- Dr. Ourania Tatsis, PhD
- Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
- --
- Joan Nickerson
- Chief Administrative Officer
- --
- Troy Lister, PhD
- Chief Scientific Officer
- --
- Allison Dorval
- Chief Financial Officer and Principal Accounting Officer
- 3.48M
- Dr. Burt A. Adelman, M.D.
- Chairman of the Board
- 451.88K
- Alexander G. Cumbo
- Independent Director
- 405.88K
- Sheila Mikhail, J.D.
- Independent Director
- 412.38K
- Lonnel Coats
- Independent Director
- 407.38K
- Michael F. Maclean
- Independent Director
- 521.07K
- Dr. Krishna Yeshwant, M.D.
- Independent Director
- 410.88K
- Jodie P. Morrison
- Independent Director
- --
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.